Denali Therapeutics Inc. Stock Sao Paulo
Stocks
D2NL34
BRD2NLBDR008
Biotechnology & Medical Research
|
Market Closed -
Sao Paulo
14:04:39 2026-07-13 EDT
|
5-day change | 1st Jan Change | ||
| 27.06 BRL | -1.31% |
|
-.--% | +25.57% |
| Market Cap | 3.2B 16.7B 2.84B 2.65B 2.41B 4.55B 308B 4.6B 32.11B 12.44B 157B 12B 11.74B 505B | P/E 2026 * |
-8.65x | P/E 2027 * | -8.72x |
|---|---|---|---|---|---|
| Enterprise Value | 2.49B 13B 2.21B 2.06B 1.88B 3.54B 240B 3.58B 24.99B 9.69B 122B 9.34B 9.14B 393B | EV / Sales 2026 * |
49.2x | EV / Sales 2027 * | 18.9x |
| Free-Float |
94.52% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Denali Therapeutics Inc.
| 1 day | -1.31% | ||
| 3 months | +38.63% | ||
| 6 months | +26.80% | ||
| Current year | +25.57% |
| Current year | 19.44 |  | 27.42 |
| 1 year | 16.06 | | 27.42 |
| 3 years | 13.48 | | 36.2 |
| 5 years | 13.48 | | 40.04 |
| 10 years | 13.48 | | 40.04 |
| Manager | Title | Age | Since |
|---|---|---|---|
Alexander Schuth
DFI | Director of Finance/CFO | 52 | 2022-04-30 |
Ryan Watts
CEO | Chief Executive Officer | 50 | 2015-07-31 |
Peter Chin
CTO | Chief Tech/Sci/R&D Officer | 58 | 2025-11-05 |
| Director | Title | Age | Since |
|---|---|---|---|
Ryan Watts
BRD | Director/Board Member | 50 | 2015-02-28 |
Jay Flatley
BRD | Director/Board Member | 73 | 2015-03-31 |
David Schenkein
BRD | Director/Board Member | 68 | 2015-03-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.31% | -.--% | - | - | 3.28B | |
| +4.16% | +3.04% | +49.37% | +94.17% | 74.41B | |
| -3.11% | -2.32% | +23.28% | +77.03% | 59.26B | |
| +0.89% | -0.77% | +5.80% | +32.89% | 47.14B | |
| -0.96% | -6.11% | +26.70% | +31.24% | 42.91B | |
| +0.36% | +3.39% | +350.59% | +646.53% | 44.13B | |
| -0.20% | -0.53% | +6.84% | +99.07% | 40.79B | |
| -0.54% | +2.93% | +9.50% | +50.41% | 30.77B | |
| -2.68% | +5.11% | +33.11% | +19.50% | 29.31B | |
| +2.33% | -8.58% | -24.55% | +340.08% | 23.71B | |
| Average | -0.11% | -0.64% | +53.40% | +154.55% | 43.6B | |
| Weighted average by Cap. | +0.23% | -0.40% | +58.36% | +145.81% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 50.57M 264M 44.95M 41.9M 38.19M 72.04M 4.87B 72.73M 508M 197M 2.48B 190M 186M 7.98B | 130M 676M 115M 107M 97.81M 184M 12.47B 186M 1.3B 504M 6.36B 486M 476M 20.44B |
| Net income | -454M -2.37B -403M -376M -343M -646M -43.69B -652M -4.56B -1.77B -22.28B -1.7B -1.67B -71.6B | -449M -2.35B -399M -372M -339M -640M -43.28B -646M -4.51B -1.75B -22.07B -1.69B -1.65B -70.93B |
| Net Debt | -708M -3.7B -630M -587M -535M -1.01B -68.22B -1.02B -7.11B -2.76B -34.79B -2.66B -2.6B -112B | -749M -3.91B -665M -620M -565M -1.07B -72.1B -1.08B -7.52B -2.91B -36.77B -2.81B -2.75B -118B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- DNLI Stock
- D2NL34 Stock
Select your edition
All financial news and data tailored to specific country editions
